What are Dendritic cell vaccine drugs?

Dendritic cell vaccine drugs are pharmacologic agents that share a common mechanism (typically targeting HER2 and other tumor-associated antigens). 0 are currently marketed, with 3 more in clinical development.

Dendritic cell vaccine

0 marketed 3 in Phase 3

This page covers all Dendritic cell vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HER2 and other tumor-associated antigens, PRAME (Preferentially Expressed Antigen in Melanoma).

Targets

HER2 and other tumor-associated antigens · PRAME (Preferentially Expressed Antigen in Melanoma)

Phase 3 pipeline (3)

Dendritic cell immunotherapy · PT. JES Kasih Nusantara Sejahterah · Oncology
Dendritic cell immunotherapy activates the patient's own dendritic cells to present tumor antigens and stimulate a cytotoxic T-cell response against cancer cells.
GLSI-100 · Greenwich LifeSciences, Inc. · Oncology
GLSI-100 is an autologous dendritic cell vaccine designed to stimulate the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens.
Lucanix™ · NovaRx Corporation · Oncology
Lucanix is a dendritic cell-based cancer vaccine that activates the immune system to recognize and attack tumor cells expressing PRAME antigen.